AI-Generated Summary

The article details how the evolving US-China rivalry is transforming biotechnology from a domain of collaboration into a strategic battlefield. This shift threatens decades of joint medical research and low-cost active pharmaceutical ingredient (API) production, potentially leading to significant setbacks for global health initiatives.

In a nutshell

This analysis provides a crucial macroeconomic and political lens on the future of pharmaceutical innovation and supply chains. It highlights how government policies and international relations profoundly impact industry operations and global health outcomes, a key insight for healthcare professionals.

Source: The Straits Times